Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjunctive Ivermectin Mass Drug Administration for Malaria Control on the Bijagos Archipelago of Guinea Bissau: A Cluster-randomized Placebo-controlled Trial

NCT04844905 is registered in ClinicalTrials.gov with London School of Hygiene and Tropical Medicine as lead sponsor.

NCT NCT04844905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04844905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjunctive Ivermectin Mass Drug Administration for Malaria Control on the Bijagos Archipelago of Guinea Bissau: A Cluster-randomized Placebo-controlled Trial
Lead sponsor
London School of Hygiene and Tropical Medicine
Phase
Phase 3
Overall status
Unknown status
Start date
May 3, 2021
Completion date
August 31, 2023
Enrollment
24,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hook worm, lymphatic filariasis, malaria,falciparum, neglected tropical diseases, scabies, soil transmitted helminths, strongyloidiasis